Opioids
Across
- 2. short acting opioid antagonist used for overdose reversal
- 4. Brand name of extended-release oxycodone
- 6. Brand name of buprenorphine/naloxone combination
- 8. prescription antidiarrheal combined with atropine
- 11. OTC peripheral μ-agonist used for diarrhea
- 14. Highly potent synthetic opioid; transdermal patch available
- 15. Brand name for fentanyl transdermal system
- 16. biased μ-agonist designed to reduce β-arrestin–mediated respiratory depression
- 17. Gold-standard opioid for severe pain; active metabolite of heroin
- 19. Partial μ-agonist used in opioid use disorder
- 20. Prodrug requiring CYP2D6 for conversion to morphine; ineffective in poor metabolizers
- 22. Weak μ-agonist + SNRI activity; seizure risk
- 24. Brand name of naloxone nasal spray
Down
- 1. High-potency synthetic opioid; CYP3A4 substrate; significant overdose risk with inhibitors
- 3. metabolite that can accumulate and causes seizures
- 5. OTC antitussive with abuse potential at high doses
- 7. Semisynthetic opioid commonly combined with acetaminophen
- 9. for intrathecal administration only
- 10. opioid with lowest histamine release
- 12. causes precipitated withdrawal in patients on chronic opioids
- 13. Long-acting opioid; QT prolongation risk
- 18. non-opioid allosteric inhibitor of peripheral sodium NaV1.8 channels
- 21. brand name of opioid that has deadly drug interaction with MAO inhibitors
- 23. Brand name for hydromorphone